Masanday, Kairi .

HRN: 25-57-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/05/2025
AMPICILLIN 500MG (VIAL)
03/05/2025
03/11/2025
IV
365mg
Q6
PCAP C
Waiting Final Action 
03/05/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/05/2025
03/11/2025
IV
95
Q24
PCAP
Waiting Final Action 
03/06/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
03/06/2025
03/12/2025
ORAL
2.5ml
Q12
PCAP
Waiting Final Action 
03/09/2025
CEFTRIAXONE 1G (VIAL)
03/09/2025
03/15/2025
IVT
730mg
OD
PCAP-C
Waiting Final Action 
03/13/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/13/2025
03/13/2025
IV
1.4g
Q6h
PCAP
Waiting Final Action 
03/13/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/13/2025
03/20/2025
IV
100mg
Od
PCAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: